Dianthus Therapeutics (DNTH) Shares Issued (2018 - 2025)
Dianthus Therapeutics (DNTH) recorded quarterly Shares Issued of $315000.0 in Q3 2025, up 346.09% quarter-over-quarter from -$128000.0 in Q2 2025, and up 199.06% on a YoY basis from $105331.2 in Q3 2024.
Dianthus Therapeutics (DNTH) Shares Issued (2018 - 2025) Analysis & Trends
Dianthus Therapeutics' Shares Issued history runs 8 years deep, the most recent figure standing at $315000.0 for Q3 2025.
- In Q3 2025, Shares Issued rose 199.06% year-over-year to $315000.0; the TTM figure through Sep 2025 stood at $39.5 million (changed N/A YoY), while the FY2024 annual figure was $39.2 million, up 783900.0% from the prior year.
- Shares Issued was $315000.0 for Q3 2025 at Dianthus Therapeutics, up from -$128000.0 in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $39.2 million in Q4 2024 to a low of -$3.3 million in Q4 2021.
- Historically, Shares Issued has averaged $3.0 million across 5 years, with a median of $129000.0 in 2025.
- The sharpest annual moves came in 2024 and 2025: Shares Issued tumbled 6460.0% in 2024, then jumped 199.06% in 2025.
- A 5-year view of Shares Issued shows it stood at -$3.3 million in 2021, then surged by 98.51% to -$49000.0 in 2022, then soared by 110.2% to $5000.0 in 2023, then jumped by 783900.0% to $39.2 million in 2024, then slumped by 99.2% to $315000.0 in 2025.
- The last three Shares Issued figures came in at $315000.0 (Q3 2025), -$128000.0 (Q2 2025), and $129000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 5.40 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 27.00 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 26,927.15 |
| 10 | Dianthus Therapeutics | 3.60 Bn | 3.19 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 315,000.00 |
| Sep 30, 2025 | 315,000.00 |
| Jun 30, 2025 | -128,000.00 |
| Jun 30, 2025 | -128,000.00 |
| Mar 31, 2025 | 129,000.00 |
| Mar 31, 2025 | 129,000.00 |
| Dec 31, 2024 | 39.20 Mn |
| Dec 31, 2024 | 39.20 Mn |
| Sep 30, 2024 | -318,000.00 |
| Sep 30, 2024 | -318,000.00 |
| Jun 30, 2024 | 47,000.00 |
| Jun 30, 2024 | 47,000.00 |
| Mar 31, 2024 | 271,000.00 |
| Mar 31, 2024 | 271,000.00 |
| Sep 30, 2023 | 5,000.00 |
| Sep 30, 2023 | 5,000.00 |
| Sep 30, 2022 | -49,000.00 |
| Sep 30, 2022 | -49,000.00 |
| Dec 31, 2021 | -3.29 Mn |
| Dec 31, 2021 | -3.29 Mn |